Trending Insights
Frequently Asked Questions
-
What value is the genome editing & genome engineering market expected to touch by 2032?
The genome editing & genome engineering market is expected to reach USD 9.62 billion by 2032.
-
What CAGR is the genome editing & genome engineering market expected to exhibit by 2032?
The genome editing & genome engineering market is expected to exhibit a CAGR of 9.3 % by 2032.
-
Which are the driving factors of the Genome Editing & Genome Engineering market?
The genome editing & genome engineering market is growing rapidly due to the rising prevalence of diseases, advances in genome editing tools, growing demand for personalized medicine, government support, and commercialization of genome editing technologies.
-
Which are the key players functioning in the Genome Editing & Genome Engineering market?
Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs, Origene, Technologies, Transposagen, Biopharmaceuticals, Editas Medicine and Crispr Therapeutics are the key players functioning in the Genome Editing & Genome Engineering market.